Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
4500000 participants
OBSERVATIONAL
2002-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver
NCT02849015
Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer
NCT02849314
Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian Cancer
NCT02849353
Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue Cancer
NCT02849379
Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea
NCT05587387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Revascularized Group
Cancer patients with diagnosis of acute myocardial infarction that was treated with PCI or CABG
Revascularization
Performing PCI or CABG
Medical Group
Cancer patients with diagnosis of acute myocardial infarction that was treated with medical treatment only
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Revascularization
Performing PCI or CABG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who were diagnosed with acute myocardial infarction after cancer diagnosis
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonnam National University
OTHER
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joo Myung Lee
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joo Myung Lee, MD, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
Seung Hun Lee, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Chonnam National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonnam National University Hospital, Chonnam National University Medical School
Gwangju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMC2023-12-027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.